Contineum Therapeutics, Inc. · NASDAQ:CTNM

Trails Edge Capital Partners, LP reported a 5.10% stake in Contineum Therapeutics, Inc. (Schedule 13G)

Event Sep 22, 2026 · Filed Oct 22, 2026

Trails Edge Capital Partners, LP reported a 5.10% stake in Contineum Therapeutics, Inc., 1,679,443 shares, as a passive investor on Sep 22, 2026. Filed Oct 22, 2026 (Schedule 13G).

Stake
5.10%
Shares
1,679,443
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Trails Edge Capital Partners, LP5.10%1,679,443
Trails Edge Biotechnology Master Fund, LP5.10%1,679,443
Ortav Yehudai5.10%1,679,443

Source

Download original · View original at SEC

Related